Aurinia Pharmaceuticals
AUPH
#5146
Rank
C$1.75 B
Marketcap
$12.27
Share price
6.43%
Change (1 day)
2.47%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): -C$57.43 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are C$0.20 Billion. In 2023 the company made an earning of -C$0.11 Billion, an increase over its 2022 earnings that were of -C$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$57.43 Million-45.06%
2023 -C$0.11 Billion-31.8%
2022 -C$0.16 Billion-39.4%
2021 -C$0.26 Billion61.9%
2020 -C$0.16 Billion-9.73%
2019 -C$0.18 Billion92.85%
2018 -C$89.72 Million36.25%
2017 -C$65.85 Million106.29%
2016 -C$31.92 Million-15.4%
2015 -C$37.73 Million65.84%
2014 -C$22.75 Million129.82%
2013 -C$9.9 Million-26.6%
2012 -C$13.49 Million
2010 -C$7.64 Million-39.22%
2009 -C$12.57 Million-43.78%
2008 -C$22.35 Million-53.19%
2007 -C$47.75 Million42.97%
2006 -C$33.4 Million-23.03%
2005 -C$43.39 Million36.1%
2004 -C$31.89 Million172.57%
2003 -C$11.7 Million484.61%
2002 -C$2.01 Million
2000 -C$9.5 Million453.81%
1999 -C$1.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$6.95 B-11,682.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$7.68 Million-87.22%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$21.35 Million-64.44%๐Ÿ‡บ๐Ÿ‡ธ USA